A narrative review on inflammaging and late-onset hypogonadism
- PMID: 38298378
- PMCID: PMC10827931
- DOI: 10.3389/fendo.2024.1291389
A narrative review on inflammaging and late-onset hypogonadism
Abstract
The increasing life expectancy observed in recent years has resulted in a higher prevalence of late-onset hypogonadism (LOH) in older men. LOH is characterized by the decline in testosterone levels and can have significant impacts on physical and mental health. While the underlying causes of LOH are not fully understood, there is a growing interest in exploring the role of inflammaging in its development. Inflammaging is a concept that describes the chronic, low-grade, systemic inflammation that occurs as a result of aging. This inflammatory state has been implicated in the development of various age-related diseases. Several cellular and molecular mechanisms have been identified as contributors to inflammaging, including immune senescence, cellular senescence, autophagy defects, and mitochondrial dysfunction. Despite the extensive research on inflammaging, its relationship with LOH has not yet been thoroughly reviewed in the literature. To address this gap, we aim to review the latest findings related to inflammaging and its impact on the development of LOH. Additionally, we will explore interventions that target inflammaging as potential treatments for LOH.
Keywords: Leydig cell; inflammaging; late-onset hypogonadism (LOH); mitochondrial; senescence-associated secretory phenotype (SASP).
Copyright © 2024 Xing, Jin and Jin.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10827931/bin/fendo-15-1291389-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10827931/bin/fendo-15-1291389-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10827931/bin/fendo-15-1291389-g003.gif)
Similar articles
-
[Senescence-associated secretory phenotype and inflammaging: the role in cardiovascular diseases.].Adv Gerontol. 2022;35(5):737-746. Adv Gerontol. 2022. PMID: 36617329 Russian.
-
[Inflammaging - contributing mechanisms and cellular signaling pathways].Postepy Biochem. 2021 Apr 26;67(2):177-192. doi: 10.18388/pb.2021_375. Print 2021 Jun 30. Postepy Biochem. 2021. PMID: 34378895 Polish.
-
Late-onset hypogonadism and lifestyle-related metabolic disorders.Andrology. 2020 Nov;8(6):1530-1538. doi: 10.1111/andr.12765. Epub 2020 Feb 16. Andrology. 2020. PMID: 31991053 Review.
-
lncRNA-Triggered Macrophage Inflammaging Deteriorates Age-Related Diseases.Mediators Inflamm. 2019 Dec 21;2019:4260309. doi: 10.1155/2019/4260309. eCollection 2019. Mediators Inflamm. 2019. PMID: 31949425 Free PMC article. Review.
-
Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects.J Endocrinol Invest. 2005;28(3 Suppl):23-7. J Endocrinol Invest. 2005. PMID: 16042356
References
-
- Yeap BB, Manning L, Chubb S, Handelsman DJ, Almeida OP, Hankey GJ, et al. . Progressive impairment of testicular endocrine function in ageing men: Testosterone and dihydrotestosterone decrease, and luteinizing hormone increases, in men transitioning from the 8th to 9th decades of life. Clin Endocrinol (Oxf) (2018) 88:88–95. doi: 10.1111/cen.13484 - DOI - PubMed
-
- Camacho EM, Huhtaniemi IT, O’Neill TW, Finn JD, Pye SR, Lee DM, et al. . Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol (2013) 168:445–55. doi: 10.1530/EJE-12-0890 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous